US Patent Issued to Regeneron Pharmaceuticals on March 25 for "Humanized dipeptidyl-peptidase IV (DPP4) animals" (New York Inventors)

ALEXANDRIA, Va., March 26 -- United States Patent no. 12,256,720, issued on March 25, was assigned to Regeneron Pharmaceuticals Inc. (Tarrytown, N.Y.).

"Humanized dipeptidyl-peptidase IV (DPP4) animals" was invented by Christos Kyratsous (Irvington, N.Y.) and Alexander Mujica (Elmsford, N.Y.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Non-human animals comprising a human or humanized DPP4 nucleic acid sequence are provided. Non-human animals that comprise a replacement of the endogenous Dpp4 gene with a human or humanized DPP4 gene, or non-human animals comprising a human or humanized DPP4 gene in addition to the endogenous Dpp4 gene are described. Non-human animals comprising a human or humanized DPP4 ge...